PER 1.41% 7.0¢ percheron therapeutics limited

Ann: Positive feedback received on Paediatric Investigation Plan, page-128

  1. 3,558 Posts.
    lightbulb Created with Sketch. 771
    Yes its very strange....always been with ANP...when it come to news..

    CR... us holders have been discussing ..MD...suggesting non dilutive funding ..

    MD always maintained Pharma interest..

    Board changes expected ...that does not possibly sit with CR and more with Partnership..and board changes news are recent after Dr CGs appointment.. hence they would know what's coming...

    CRO has been paid a decent amount of money to get started ...so who paid that?? They wouldn't start work with a couple of million...

    EMA news been on hold...Sarepta CR reasons unknown...

    Too many questions ...May be halt on Monday??

    as EMA news are overdue...There will be phone calls to ANP office if this doesn't come on Monday...

    IMO..
    Last edited by arjay: 22/10/21
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.